# Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment

> **NCT00932867** · — · COMPLETED · sponsor: **Bayer** · enrollment: 3114 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Kinzal/Pritor (Telmisartan, BAY68-9291)

## Key facts

- **NCT ID:** NCT00932867
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-06
- **Final completion:** 2009-08
- **Target enrollment:** 3114 (ACTUAL)
- **Last updated:** 2010-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00932867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00932867, "Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00932867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*